Hussman Strategic Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,200
Closed -$432K 279
2023
Q3
$432K Sell
4,200
-2,000
-32% -$216K 0.08% 247
2023
Q2
$715K Sell
6,200
-14,600
-70% -$1.66M 0.13% 238
2023
Q1
$2.21M Hold
20,800
0.35% 118
2022
Q4
$2.31M Sell
20,800
-10,200
-33% -$1.04M 0.38% 102
2022
Q3
$2.67M Buy
+31,000
New +$2.77M 0.46% 76
2022
Q1
Sell
-10,400
Closed -$797K 342
2021
Q4
$797K Buy
+10,400
New +$828K 0.17% 186
2021
Q2
Sell
-37,728
Closed -$2.77M 370
2021
Q1
$2.77M Buy
+37,728
New +$2.78M 0.57% 50
2018
Q3
Sell
-36,680
Closed -$2.12M 238
2018
Q2
$2.12M Buy
+36,680
New +$2.07M 0.57% 78
2014
Q1
Sell
-2,751
Closed -$131K 211
2013
Q4
$131K Hold
2,751
0.01% 176
2013
Q3
$125K Hold
2,751
0.01% 185
2013
Q2
$122K Buy
+2,751
New +$123K 0.01% 209

Other funds holding MRK

Hussman Strategic Advisors's MRK Position: Q4 2023 in Review

Hussman Strategic Advisors sold out of Merck (MRK) in Q4 2023, closing a stake of 4,200 shares — an estimated $432K sold.

Hussman Strategic Advisors first reported a position in MRK in Q2 2013 and held it in 11 quarters. The position peaked at $2.77M in Q1 2021. 3,434 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • Hussman Strategic Advisors reported no remaining Merck position as of Q4 2023 after selling out during the quarter.
  • Hussman Strategic Advisors sold 4,200 Merck shares in Q4 2023, an estimated $432K.
  • Hussman Strategic Advisors first reported a position in Merck in Q2 2013 and held it in 11 quarters.
  • Hussman Strategic Advisors's Merck position peaked at $2.77M in Q1 2021.
  • 3,434 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on Hussman Strategic Advisors's 13F filing for Q4 2023, filed 1 Feb 2024.